PMC7748915_01
First OPG with multicystical lesion in the left mandible surrounding teeth 33 to 36 (2010).
CRID2020-8867320.001.jpg
PMC7748915_01_CRID2020-8867320.001.jpg
fig1
The orthopantomogram (OPG) showed a multilocular radiolucency, with fine trabeculation, extending from the left canine, towards the first molar (Figure 1) with no root resorption.
Representative photomicrograph of odontogenic myxoma (hematoxylin and eosin, original magnification 100x).
CRID2020-8867320.002.jpg
PMC7748915_01_CRID2020-8867320.002.jpg
fig2
Odontogenic epithelium was absent, and clear margins were confirmed (Figures 2 and 3).
Spindle-shaped cells with long fine cytoplasmic processes, within an abundant, myxoid ground substance, containing small capillaries and fragments of bone trabecula (hematoxylin and eosin, original magnification 200x).
CRID2020-8867320.003.jpg
PMC7748915_01_CRID2020-8867320.003.jpg
fig3
Odontogenic epithelium was absent, and clear margins were confirmed (Figures 2 and 3).
OPG 2 years after resective surgery (2013).
CRID2020-8867320.004.jpg
PMC7748915_01_CRID2020-8867320.004.jpg
fig4
A control OPG (Figure 4) and clinical examination (Figures 5 and 6) showed complete recovery with a residual defect in the alveolar extension and left concavity.
Clinical appearance after 2 years postresective surgery-frontal view.
CRID2020-8867320.005.jpg
PMC7748915_01_CRID2020-8867320.005.jpg
fig5
A control OPG (Figure 4) and clinical examination (Figures 5 and 6) showed complete recovery with a residual defect in the alveolar extension and left concavity.
Bone splitting with piezo bone saw during implant placement.
CRID2020-8867320.006.jpg
PMC7748915_01_CRID2020-8867320.006.jpg
fig6
A control OPG (Figure 4) and clinical examination (Figures 5 and 6) showed complete recovery with a residual defect in the alveolar extension and left concavity.
Bone splitting with bone mallet and chisel during implant placement.
CRID2020-8867320.007.jpg
PMC7748915_01_CRID2020-8867320.007.jpg
fig7
Austria: power 90%, cooling 80%, "power" operating mode), and two narrow diameter implants (Straumann, Bone Level Roxolid 3.3 x 10 mm, Basel, Switzerland) were placed at positions 32 and 36 (Figures 7 and 8). After implant placement augmentation was performed with xenogenic bone material (Cerabone, Botiss, Germany) and a resorptive native pericardium membrane (Jason membrane 15 x 20 mm, Botiss, Germany), the sutures were removed on the 10th postoperative day at which time the surgical site was healing as expected.
Panoramic view after implant placement-2013.
CRID2020-8867320.008.jpg
PMC7748915_01_CRID2020-8867320.008.jpg
fig8
Austria: power 90%, cooling 80%, "power" operating mode), and two narrow diameter implants (Straumann, Bone Level Roxolid 3.3 x 10 mm, Basel, Switzerland) were placed at positions 32 and 36 (Figures 7 and 8). After implant placement augmentation was performed with xenogenic bone material (Cerabone, Botiss, Germany) and a resorptive native pericardium membrane (Jason membrane 15 x 20 mm, Botiss, Germany), the sutures were removed on the 10th postoperative day at which time the surgical site was healing as expected.
OPG (2020):9-year follow-up.
CRID2020-8867320.009.jpg
PMC7748915_01_CRID2020-8867320.009.jpg
fig9
No tumor recurrence was found on the follow-up OPG and CBCT for 7 years after implant placement and 9 years postresective surgery (Figures 9-11).
Clinical situation with locators (2020).
CRID2020-8867320.010.jpg
PMC7748915_01_CRID2020-8867320.010.jpg
fig10
No tumor recurrence was found on the follow-up OPG and CBCT for 7 years after implant placement and 9 years postresective surgery (Figures 9-11).
Clinical appearance after 9 years postsurgery and 7 years after implanto-prosthodontic rehabilitation.
CRID2020-8867320.011.jpg
PMC7748915_01_CRID2020-8867320.011.jpg
fig11
No tumor recurrence was found on the follow-up OPG and CBCT for 7 years after implant placement and 9 years postresective surgery (Figures 9-11).